Polarean Imaging plc

Equities

POLX

GB00BF3DT583

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 11:35:12 2024-04-26 am EDT			5-day change	1st Jan Change
3.75 ^GBX	-1.32%		-3.85%	-40.00%

Apr. 16	Nexteq confident of meeting full-year expectations	AN
Apr. 16	Polarean Imaging Secures New Patent for Hyperpolarized Imaging Platform	MT

Polarean Imaging strategic parter raises stake to above 10%

January 15, 2024 at 06:22 am EST

Polarean Imaging PLC - London-based developer of medical imaging devices providing magnetic resonance imaging of the lungs - Strategic partner NUKEM Isotopes GmbH buys 9.5 million Polarean shares from Amati Global Investors Ltd, raising its stake to 10.5% from 6.1%. Alzenau, Germany-based NUKEM is a trading company in stable isotopes and noble gases. Amati retains a 4.6% stake in Polarean, down from its last reported level of 9.8%. The shares purchased by NUKEM are worth GBP725,800 at Polarean's current market price.

Current stock price: 7.64 pence, up 1.8%

12-month change: down 85%

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Latest news about Polarean Imaging plc

Nexteq confident of meeting full-year expectations	Apr. 16	AN
Polarean Imaging Secures New Patent for Hyperpolarized Imaging Platform	Apr. 16	MT
Polarean Imaging shares sink after announcing a costly strategic plan	Feb. 29	AN
Polarean Imaging strategic parter raises stake to above 10%	Jan. 15	AN
Nukem Isotopes Ups Polarean Imaging Stake	Jan. 15	MT
Polarean shares jump on Xenoview polariser order	Dec. 07	AN
AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean	Dec. 07	AN
Polarean Imaging Plc Receives First De Novo Order for A New XENOVIEWtm Polariser	Dec. 07	CI
Polarean Imaging Teams up with Vida Diagnostics on Magnetic Resonance Imaging Platform	23-09-08	MT
Polarean Imaging partners with Vida Diagnostics on MRI solutions	23-09-08	AN
Polarean Imaging plc Partnership with VIDA Diagnostics, Inc. to Streamline Adoption of Advanced MRI of the Lungs	23-09-08	CI
FTSE 100 Closes Up 0.21% on Pound Weakness	23-09-07	DJ
UK Inflation Expectations Fall, Boosting Prospects for BOE Rate Pause	23-09-07	DJ
Polarean withdraws commercial targets on revenue drop	23-09-07	AN
UK Gilt Yields Fall on Rising Expectations of a BOE Rate Pause	23-09-07	DJ
FTSE 100 Falls After Weak Performance in Asian Markets	23-09-07	DJ
AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends	23-09-07	AN
Sterling Could Fall on Expectations of a BOE Rate Pause	23-09-07	DJ
Earnings Flash (POLX.L) POLAREAN IMAGING Posts H1 Loss $-0.04	23-09-07	MT
Earnings Flash (POLX.L) POLAREAN IMAGING Posts H1 Revenue $142.4M	23-09-07	MT
Polarean Imaging plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-07	CI
Polarean Imaging product cleared for US Medicare payments	23-08-29	AN
Polarean Imaging Gets 510(k) Clearance for Xenoview 3.0T Chest Coil	23-08-03	MT
Polarean Receives Clearance for New MRI Chest Coil	23-08-03	CI
Polarean hails US FDA approval on Philips MRI configuration	23-08-03	AN

Chart Polarean Imaging plc

Duration

Period

More charts

Company Profile

Polarean Imaging PLC is a medical-imaging technology company, with an investigational drug-device combination product for magnetic resonance imaging (MRI). The Company and its subsidiary company operate as investigational drug-device combination companies operating in the high-resolution medical imaging research space. The Company develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue membrane, and into the pulmonary bloodstream. The Companyâs technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform. It operates in Canada, Germany, United Kingdom and United States. The Companyâs subsidiary is Polarean, Inc.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-11 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Polarean Imaging plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.0467 USD

Average target price

0.547 USD

Spread / Average Target

+1,071.14%

Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
POLAREAN IMAGING PLC	-40.00%	10.1M
SARTORIUS AG	-12.91%	19.08B
QUIDELORTHO CORPORATION	-46.21%	2.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.15%	1.87B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.12%	1.61B
BIOTAGE AB	+23.78%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.69%	1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD	-20.89%	905M
REVENIO GROUP OYJ	-7.14%	716M
VAREX IMAGING CORPORATION	-18.10%	682M

Medical Diagnostic & Testing Equipment